Fujirebio Expands Access in Canada to Blood-based Neurology Testing with Health Canada Class II Medical Device Licenses for the Lumipulse® G NfL Blood and Lumipulse G pTau 217 Plasma Assays


Fujirebio is a diagnostics company with over 75 years of experience delivering innovative solutions to healthcare providers, pharmaceutical companies, and in vitro diagnostics (IVD) partners worldwide. Leveraging world-class expertise in neurology, oncology, infectious diseases, and beyond, and assays available on the robust LUMIPULSE® G platform, Fujirebio’s open business model accelerates access to breakthrough diagnostics through strategic partnerships across the life science industry.



Source link

  • Related Posts

    Pulsar Launches New Corporate Website

    This Announcement and the Information Contained Herein Is Restricted and Is Not for Release, Publication or Distribution, in Whole or in Part, Directly or Indirectly, in, Into or from Australia,…

    Can pineapples thrive in Africa’s Sahel? A Burkina Faso farmer says the answer is yes

    BOBO-DIOULASSO, Burkina Faso (AP) — The soil beneath Oumarou Compaoré’s boots is sandy and stony. It’s hardly the lush setting usually needed to support growing pineapples. But this farm in…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Pulsar Launches New Corporate Website

    Today’s NYT Mini Crossword Answers for Tuesday, Sept. 1

    Today’s NYT Mini Crossword Answers for Tuesday, Sept. 1

    The 9 Reformation Capsule Wardrobe Buys That Come Editor-Approved

    The 9 Reformation Capsule Wardrobe Buys That Come Editor-Approved

    Football gossip: Alvarez, Nyoni, Larsson, Woltemade

    Football gossip: Alvarez, Nyoni, Larsson, Woltemade

    Capcom Spotlight Presentation Kicks Off TGS 2026 Later This Month

    Capcom Spotlight Presentation Kicks Off TGS 2026 Later This Month

    Markiplier is now GoPro’s biggest shareholder

    Markiplier is now GoPro’s biggest shareholder